HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcus Vinicius Gomez Selected Research

CTK 01512-2

7/2022Systemic, Intrathecal, and Intracerebroventricular Antihyperalgesic Effects of the Calcium Channel Blocker CTK 01512-2 Toxin in Persistent Pain Models.
1/2021Analgesic effects of Phα1β toxin: a review of mechanisms of action involving pain pathways.
6/2020Analgesic effects of the CTK 01512-2 toxin in different models of orofacial pain in rats.
2/2020Recombinant peptide derived from the venom the Phoneutria nigriventer spider relieves nociception by nerve deafferentation.
4/2017Pre-clinical evaluation of voltage-gated calcium channel blockers derived from the spider P. nigriventer in glioma progression.
1/2017The peptide Phα1β, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marcus Vinicius Gomez Research Topics

Disease

20Pain (Aches)
07/2022 - 11/2008
13Hyperalgesia
07/2022 - 02/2011
8Neuralgia (Stump Neuralgia)
04/2020 - 11/2008
5Chronic Pain
07/2022 - 02/2011
4Ischemia
07/2022 - 09/2008
3Fibromyalgia (Fibrositis)
05/2021 - 04/2014
2Hypersensitivity (Allergy)
07/2022 - 02/2020
2Visceral Pain
01/2021 - 11/2014
2Constipation
12/2020 - 06/2014
2Ganglion Cysts (Ganglion)
03/2016 - 09/2008
1Peripheral Nervous System Diseases (PNS Diseases)
07/2022
1Pancreatitis
01/2021
1Hypercalcemia (Milk Alkali Syndrome)
01/2021
1Acute Pain
01/2021
1Postoperative Pain
12/2020
1Facial Pain (Myofacial Pain)
06/2020
1Inflammation (Inflammations)
01/2019
1Cancer Pain
07/2017
1Melanoma (Melanoma, Malignant)
07/2017
1Neoplasms (Cancer)
04/2017
1Glioma (Gliomas)
04/2017
1Diabetic Neuropathies (Diabetic Neuropathy)
10/2011
1Hyperthermia
02/2011
1Hepatic Encephalopathy
08/2010
1Heart Failure
04/2010
1Heart Diseases (Heart Disease)
04/2010
1Autonomic Nervous System Diseases (Dysautonomia)
04/2010
1Brain Injuries (Brain Injury)
11/2009
1Malignant Hyperthermia
03/2006
1Neuroblastoma
09/2005

Drug/Important Bio-Agent (IBA)

9Analgesics (Analgesic Drugs)IBA
05/2021 - 11/2008
8CalciumIBA
01/2021 - 03/2006
7Calcium Channels (Calcium Channel)IBA
01/2021 - 09/2008
6CTK 01512-2IBA
07/2022 - 01/2017
6Peptides (Polypeptides)IBA
01/2021 - 10/2011
5Calcium Channel Blockers (Blockers, Calcium Channel)IBA
07/2022 - 11/2008
4Conotoxins (Conotoxin)IBA
01/2021 - 01/2013
4Morphine (MS Contin)FDA LinkGeneric
01/2021 - 06/2014
4Pharmaceutical PreparationsIBA
12/2020 - 11/2008
4Spider Venoms (Venom, Spider)IBA
01/2019 - 11/2009
3Pregabalin (Lyrica)FDA Link
05/2021 - 04/2014
3Reserpine (Serpasil)FDA Link
05/2021 - 04/2014
3Opioid Analgesics (Opioids)IBA
01/2021 - 06/2014
3Capsaicin (Zostrix)FDA Link
01/2020 - 01/2013
3VenomsIBA
01/2019 - 09/2005
3Freund's AdjuvantIBA
01/2013 - 02/2011
3Tx3 neurotoxinIBA
10/2011 - 09/2005
3Proteins (Proteins, Gene)FDA Link
07/2011 - 03/2006
3Glutamic Acid (Glutamate)FDA Link
07/2011 - 11/2009
2Paclitaxel (Taxol)FDA LinkGeneric
07/2022 - 04/2020
2Diclofenac (SR 38)FDA LinkGeneric
05/2021 - 04/2014
2Formaldehyde (Formol)FDA Link
01/2021 - 07/2017
2ziconotide (Prialt)FDA Link
02/2020 - 11/2008
2TRPV1 receptorIBA
01/2020 - 02/2011
2Cholinergic Agents (Cholinergics)IBA
10/2017 - 04/2010
2Neuroprotective AgentsIBA
03/2016 - 09/2008
2NeurotoxinsIBA
01/2013 - 09/2005
2Oxygen (Dioxygen)IBA
07/2011 - 11/2009
2Glucose (Dextrose)FDA LinkGeneric
07/2011 - 11/2009
2Retinaldehyde (Retinal)IBA
07/2011 - 09/2008
1prostaglandin-inositol cyclic phosphateIBA
07/2022
1Sucrose (Saccharose)IBA
05/2021
1AmylasesFDA Link
01/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1CeruletideIBA
01/2021
1Lipase (Acid Lipase)FDA Link
01/2021
1N-Type Calcium Channels (N-Type Calcium Channel)IBA
06/2020
1TRPA1 Cation ChannelIBA
06/2020
1Chemokine ReceptorsIBA
02/2020
1Interleukin-6 (Interleukin 6)IBA
02/2020
1plerixaforFDA Link
02/2020
1Cholinergic ReceptorsIBA
10/2017
1Annexin A5IBA
04/2017
1Propidium (Propidium Iodide)IBA
04/2017
1Bortezomib (Velcade)FDA Link
01/2017
12,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA
01/2017
1N-Methylaspartate (NMDA)IBA
03/2016
1Rice Bran OilIBA
01/2016
1ResveratrolIBA
01/2016
1Serotonin (5 Hydroxytryptamine)IBA
04/2014
1Dopamine (Intropin)FDA LinkGeneric
04/2014
1Streptozocin (Streptozotocin)FDA Link
10/2011
1R-Type Calcium Channels (R-Type Calcium Channel)IBA
10/2011
1eriodictyolIBA
02/2011
1AntioxidantsIBA
02/2011
1N- (4- (6- (4- trifluoromethylphenyl)pyrimidin- 4- yloxy)benzothiazol- 2- yl)acetamideIBA
02/2011
1Thioacetamide (Thioacetamid)IBA
08/2010
1omega-Conotoxin GVIAIBA
11/2009
1omega-conotoxin-MVIICIBA
11/2009
1Dantrolene (Dantrium)FDA LinkGeneric
09/2008
11,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl esterIBA
09/2008

Therapy/Procedure

4Spinal Injections
04/2020 - 10/2011
3Analgesia
01/2021 - 11/2008
2Therapeutics
12/2020 - 06/2014
1Intravenous Administration
05/2021
1Injections
07/2017
1Subcutaneous Injections
01/2016
1Ligation
10/2011